Myomo appoints William J. Febbo to Board, effective April 14, 2026

MYOMO, INC.

Febbo, 57, is CEO of Performance Health Systems and former CEO of OptimizeRx (OPRX), where he grew revenue from $5M to $92M.
He received 45,000 RSUs vesting on first anniversary, plus $60K annual cash retainer and $85K annual RSU retainer.
Appointment expands Board to six directors; Febbo serves as Class II director until 2028 annual meeting.
Chairman Paul Gudonis cited Febbo's expertise in scaling direct-to-patient healthcare and capital markets credibility.
Febbo co-founded Merriman Holdings and Digital Capital Network; also MIT linQ faculty and Harvard Business School mentor.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.